company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18513000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18513000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7281000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7281000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11232000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4268000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13855000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18123000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6891000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3892000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,153000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3739000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,567000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11197000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16501000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16501000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7382000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7382000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9119000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3905000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14482000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18387000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9268000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4175000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1001000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3174000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,655000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13097000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55285000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,2012-02-01 18:58:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55285000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17841000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17841000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6617000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6617000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11224000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3795000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15883000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19678000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8454000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3048000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11502000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11502000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11502000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,4304000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15806000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56129000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,2012-05-03 11:52:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56129000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19046000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19046000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7636000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7636000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11410000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4293000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19278000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23571000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12161000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9608000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1872000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11480000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23641000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23641000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,1891000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21750000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-5526000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16224000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.02
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.02
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55447000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.02
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22131000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22131000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6444000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6444000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15687000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3720000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12598000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16318000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-631000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2955000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2949000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57025000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23228000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23228000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6266000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6266000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3782000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3836000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63400000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63400000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60004000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,2013-02-06 16:37:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19113000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19113000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5291000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5291000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13822000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3226000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16094000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19320000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5498000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2678000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2670000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74817000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,2013-05-07 17:16:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6260000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6260000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14403000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4474000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14877000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4948000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3097000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3082000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8030000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8030000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8030000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8030000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70619000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6539000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6539000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9294000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4780000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13534000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18314000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9020000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2759000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2748000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92606000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18377000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18377000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7909000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7909000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10468000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4610000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13941000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18551000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8083000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2860000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2848000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10931000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10931000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10931000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10931000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105403000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,2014-02-05 16:56:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9955000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9955000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8624000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8624000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1331000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5001000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15105000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20106000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18775000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2819000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21594000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21594000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21594000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21594000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116665000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,2014-05-08 17:57:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7006000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7006000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18409000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5233000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16840000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22073000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3664000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13999000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13985000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17649000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17649000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17649000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17649000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107794000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14228000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14228000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10658000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10658000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3570000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5179000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11704000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16883000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13313000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2383000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2367000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117509000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14066000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14066000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13110000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13110000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,956000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5472000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9487000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14959000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14003000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2428000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2405000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,126200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,123921000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 17:30:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7773000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7773000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10756000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10756000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-2983000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5405000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14131000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19536000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22519000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2435000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2413000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125471000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125471000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,124700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 21:50:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6011000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6011000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11441000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11441000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-5430000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14502000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20353000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25783000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2470000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2454000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123403000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123403000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,123600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12177000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12177000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-6108000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6799000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12190000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18989000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25097000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2509000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2496000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131826000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131826000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131400000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26919000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26919000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13821000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8078000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11817000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19895000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6074000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2545000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2537000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,133815000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,133815000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,2016-02-05 16:10:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6601000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6601000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12140000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12140000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-5539000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8187000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11817000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-80010000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-60006000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54467000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2577000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3840000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139769000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,166265000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,138800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 17:26:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12320000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12320000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6977000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6977000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5343000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8369000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18618000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21644000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2616000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9885000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1641000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8910000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12734000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12734000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136679000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141692000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q4,2015-04-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16197000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16197000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6212000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6212000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9985000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7358000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20998000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28356000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18371000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2656000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2616000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142216000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142216000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139900000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35430000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35430000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29767000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9938000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51289000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2693000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2642000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 08:11:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43047000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43047000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5847000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5847000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8406000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48802000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57208000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20008000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2743000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2667000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,143338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,141700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 08:04:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43205000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43205000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5444000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5444000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37761000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10565000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49504000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22308000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2782000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2706000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142964000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142964000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q4,2016-04-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39271000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39271000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8845000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8845000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30426000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7862000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46563000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54425000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23999000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2979000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4609000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28608000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28608000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28608000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28608000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,143000000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,2016-07-01,2016-09-30,2017-10-31 09:22:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44523000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44523000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9026000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9026000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35497000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8834000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46469000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55303000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19806000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3107000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,212000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3495000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23301000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23301000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23301000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23301000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,168127000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,168127000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,168127000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,2016-10-01,2016-12-31,2018-02-06 08:11:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33280000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33280000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7432000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7432000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25848000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57783000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31935000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3095000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,228000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-515000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3382000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35317000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35317000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35317000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35317000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,169020000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,169020000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,168200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 08:14:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33778000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33778000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10092000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10092000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23686000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10926000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50024000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3152000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1183000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1285000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3254000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29592000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29592000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29592000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29592000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,163207000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,163207000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q4,2017-04-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12048000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65252000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35506000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3213000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,525000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2488000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174772000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174772000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42218000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42218000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42218000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11607000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56329000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67936000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25718000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9290000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1255000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8335000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34053000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34053000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34053000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34053000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,199852000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199852000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,200300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,2017-10-01,2017-12-31,2019-02-05 08:07:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66367000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66367000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66367000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16773000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71348000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88121000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21754000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2361000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1364000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1097000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,208994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,207700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,2018-01-01,2018-03-31,2019-05-07 08:14:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35437000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35437000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59374000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59374000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-23937000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18072000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4940000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23012000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46949000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2407000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1395000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2187000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3199000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50148000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52448000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52448000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52448000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198490000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,198490000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,199100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56910000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56910000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,195000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,195000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56715000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24890000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55550000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80440000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23725000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1559000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-65000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1086000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212193000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212193000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,206800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,82549000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,82549000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,786000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,786000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81763000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30473000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62120000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,92593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10830000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2818000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2286000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-532000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11362000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11362000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11362000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11362000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215872000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215872000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,227200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,2018-10-01,2018-12-31,2019-02-05 08:07:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64677000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64677000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1042000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1042000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63635000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35548000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,65541000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101089000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37454000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2863000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2823000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219913000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219913000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,220600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,2019-05-07 08:14:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
